Vicat (VCT) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
21 Sep, 2026Executive summary
Organic sales were stable at +0.2% like-for-like, but down -2.7% reported due to negative currency effects, with resilience in Switzerland, the Mediterranean, and Brazil offsetting slowdowns in the US, India, and Africa.
EBITDA declined -2.0% like-for-like to €331 million, while consolidated net income rose +6.3% like-for-like to €116 million.
Free cash flow improved to €44 million from -€23 million, and net debt was reduced by €190 million year-over-year.
Strategic moves included the acquisition of Realmix in Brazil and a tender offer for minority interests in Sinai Cement, Egypt.
The group maintained resilience amid geopolitical uncertainty, with strong performance in emerging markets and a balanced exposure to developed and emerging markets.
Financial highlights
Consolidated sales reached €1,885 million in H1 2025, down -2.7% reported, but up +0.2% like-for-like year-over-year.
EBITDA was €331 million, down -6.3% reported and -2.0% like-for-like; margin at 17.5% (-0.7 pts year-over-year).
Recurring EBIT: €169 million, down -10.0% reported, -4.4% like-for-like; margin at 9.0%.
Net income: €116 million, up +6.3% like-for-like; net income group share €102 million (+3.1% like-for-like); margin at 6.1%.
Free cash flow: €44 million, a significant improvement from -€23 million in H1 2024.
Outlook and guidance
2025 EBITDA growth guidance updated to +2% to +5% like-for-like due to currency headwinds.
Sales growth targeted on a like-for-like basis; expecting stronger H2, especially in Egypt, Brazil, and from Kiln 6 in Senegal.
Net CapEx guidance for 2025 confirmed at €280 million; deleveraging target of 1.3x by year-end 2025 and below 1x by 2027.
Committed to maintaining EBITDA margin of at least 20% through 2027.
Latest events from Vicat
- Strong H1 2026 growth and upgraded outlook, driven by emerging markets and US recovery.VCT
Q2 2026 - Q1 2026 sales rose 8.5% like-for-like, with robust growth and guidance reaffirmed despite FX headwinds.VCT
Q1 2026 TU - Sales +3.3% LFL, EBITDA +3.7% LFL, strong cash flow, and major decarbonization progress.VCT
H2 2025 - Q3 2025 saw 4.9% organic sales growth and strategic progress despite FX headwinds.VCT
Q3 2025 TU - 3.3% organic sales growth and EBITDA targets confirmed, despite currency and market headwinds.VCT
Q3 2024 TU - EBITDA up 12.3% and organic sales up 4.8% in H1 2024, led by US and emerging markets.VCT
H1 2024 - Stable Q1 2025 sales and confirmed guidance, with growth expected from new projects.VCT
Q1 2025 TU - Record EBITDA and cash flow, with US growth and climate progress offsetting European weakness.VCT
H2 2024